What are T7 Tag antibodies?
Anti-T7 Tag antibodies are immunoglobulins that specifically recognize and bind the T7 Tag, a short peptide epitope derived from the leader sequence of bacteriophage T7 gene 10 capsid protein. In research applications, these antibodies are used to detect T7-tagged recombinant proteins in tissue samples, cell lysates, and cultured cells. Because the T7 Tag is genetically fused to a protein of interest rather than occurring naturally, detecting it allows researchers to track recombinant protein expression, localization, and purification independent of the native protein's own antigenicity. This makes T7 Tag antibodies a general-purpose tool across molecular biology and protein expression research.
Catalog highlights and purchasing considerations
About the Biocompare T7 Tag antibody catalog
The Biocompare antibody search tool lists T7 Tag antibodies from a limited number of suppliers, with western blot, ELISA, and immunohistochemistry among the most common validated applications. Several T7 Tag antibodies mentioned here have been cited across a range of molecular biology research, including studies on cell-free bacteriophage T7 assembly under simulated microgravity, in vivo capsid engineering of bacteriophages for oriented surface conjugation, and use of the tag to track recombinant constructs in a neuronal tau aggregation drug discovery model.
Considerations when choosing a T7 Tag antibody for research
Confirm that the antibody's intended target is accurate, as many genes carry synonym symbols that can create ambiguity across suppliers. Specificity should be verified against the immunogen sequence or region listed on the product datasheet, since antibodies raised against different epitopes of the same protein can behave differently across applications. Beyond specificity, several target-related attributes can affect antibody binding, including subcellular location, extracellular and cytoplasmic domain boundaries for membrane-associated targets, tissue specificity, post-translational modifications, and the presence of additional isoforms or disease-associated variants. In parallel, antibody-specific selection criteria warrant consideration, including clonality (monoclonal versus polyclonal), host species, species reactivity, and conjugate or label choice suited to the detection method. Supplier validation data, such as western blot bands at the expected molecular weight, immunohistochemistry staining patterns consistent with known tissue distribution, and knockout or knockdown controls, should also be carefully reviewed before purchase.